The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABIVAX SA SPONSORED ADS 00370M103   5,505,862 752,167 SH   SOLE   752,167 0 0
AGIOS PHARMACEUTICALS INC COM 00847X104   20,579,561 626,280 SH   SOLE   626,280 0 0
ANIKA THERAPEUTICS INC COM 035255108   23,622,240 1,435,130 SH   SOLE   1,435,130 0 0
BIOCRYST PHARMACEUTICALS INC COM 09058V103   22,529,409 2,995,932 SH   SOLE   2,995,932 0 0
ENANTA PHARMACEUTICALS INC COM 29251M106   1,062,750 184,826 SH   SOLE   184,826 0 0
EVOLUS INC COM 30052C107   29,723,964 2,692,388 SH   SOLE   2,692,388 0 0
EXELIXIS INC COM 30161Q104   50,806,809 1,525,730 SH   SOLE   1,525,730 0 0
LIQUIDIA CORPORATION COM NEW 53635D202   115,527,564 8,118,592 SH   SOLE   8,118,592 0 0
MERUS N V COM N5749R100   10,722,750 255,000 SH   SOLE   255,000 0 0
MINERALYS THERAPEUTICS INC COM 603170101   12,447,318 1,011,155 SH   SOLE   1,011,155 0 0
SAGE THERAPEUTICS INC COM 78667J108   16,575,281 3,052,538 SH   SOLE   3,052,538 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106   66,728,614 1,436,878 SH   SOLE   1,436,878 0 0
VERRICA PHARMACEUTICALS INC COM 92511W108   5,200,781 7,429,687 SH   SOLE   7,429,687 0 0
Y-MABS THERAPEUTICS INC COM 984241109   13,843,299 1,767,982 SH   SOLE   1,767,982 0 0